Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-09-15
1980-08-26
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260553A, 260556A, 260559T, 260559A, 424250, 424263, 424270, 424273R, 424274, 424275, 424285, 424321, 424322, 424324, A61K 31275, A61K 3118, A61K 3117, A61K 31165
Patent
active
042195616
ABSTRACT:
1-Aryloxy-3-(tri- or tetra-acylamido)-alkylamino-propan-2-ol derivatives, processes for their manufacture and pharmaceutical compositions containing them. The compounds possess .beta.-adrenergic blocking activity and are useful in the treatment of heart diseases such as angina pectoris, cardiac arrhythmias and hypertension. Representative of the compounds disclosed is 1-(o-chlorophenoxy)-3-.beta.-(phenylacetamido-.gamma.-butyramido-.gamma.-b utyramido)-ethylamino-2-propanol.
REFERENCES:
patent: 3928412 (1975-12-01), Smith
patent: 3930016 (1975-12-01), Berntsson et al.
patent: 3944611 (1976-03-01), Smith
patent: 3959369 (1976-05-01), Smith
patent: 4010189 (1977-03-01), Smith
patent: 4034106 (1977-07-01), Smith
patent: 4035420 (1977-07-01), Berntsson et al.
patent: 4041075 (1977-08-01), Smith
patent: 4083992 (1978-04-01), Smith
patent: 4115409 (1978-09-01), Large et al.
Imperial Chemical Industries Limited
Waddell Frederick E.
LandOfFree
Alkanolamine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkanolamine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkanolamine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1305679